NanoCellect Biomedical Expands its Global Distribution Network to Middle East and Africa

News | September 23, 2021
NanoCellect Biomedical Expands its Global Distribution Network to Middle East and Africa

DUBAI, September 23, 2021 – NanoCellect Biomedical Inc. a privately-held life sciences company, focused on developing microfluidic based cell analysis and sorting solutions, has signed an agreement appointing Alliance Global (AGBL Group) as the exclusive distributor in the Middle East, Africa, Levant, Turkey, Pakistan, Bangladesh and Sri Lanka.

 

Dr. Will Alaynick, Co-founder and Vice President International at NanoCellect commented that, “NanoCellect is eagerly supporting our colleagues in performing cell line development and single-cell ‘omics research. In addition, we have helped numerous infectious disease researchers with our sterile, contained cartridges—including the novel coronavirus. Reaching additional researchers in Africa who are addressing malaria, and several viral diseases is what makes our efforts at NanoCellect so rewarding.”

 

“We are very happy to establish a strategic partnership with NanoCellect. We believe that NanoCellect’s products will add great value to our customers and markets.” said Dr. Nassim-Marie Hambouz, AGBL’s Vice President of Commercial Operations.

 

About AGBL 

Alliance Global Group of companies is the largest biomedical gateway in the Middle East, Africa, and Asia. The group is dedicated to bringing innovative technologies and products to researchers, clinicians, and diagnostic users in the region’s emerging healthcare market. The group’s mission is to improve lives through novel biomedical technologies and products. For more information visit www.agbl.net.

 

About NanoCellect Biomedical

NanoCellect’s mission is to facilitate breakthrough biomedical discoveries by making cell sorting and analysis technology portable, affordable, and easy to use. Its WOLF platform is used in a growing number of scientific applications including antibody discovery, cell line development, single cell DNA sequencing, genomic sample preparation, CRISPR genomic editing, and plant and animal genomics. For more information, visit https://nanocellect.com/